BIB

ProShares Ultra NASDAQ Biotechnology

BIB Fund Description

The ProShares Ultra NASDAQ Biotech provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.

BIB Factset Analytics Insight

BIB is a popular leveraged play on the NASDAQ Biotechnology Index, which is also tracked in unlevered form by the hugely popular iShares' IBB, and is heavily focused on Nasdaq's biotechnology and pharmaceutical firms with a large-cap bias. The fund gains its 2x leveraged exposure to the index through swap agreements with multiple counterparties, and rebalances its exposure daily. Like all geared funds that rebalance daily, BIB is meant for short-term trading, since compounding effects over the long term could create vast differences from expected returns—for good or for ill. BIB has been around since April 2010 and is well established, with healthy assets, which puts any closure risk to rest. Yet traders should be cautious: daily volume is strong, but spreads and volatility can be high, likely reflecting the volatile underlying assets.

BIB MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of November 19, 2017 the ProShares Ultra NASDAQ Biotechnology MSCI ESG Fund Quality Score is 4.42 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. BIB ranks in the 0th percentile within its peer group and in the 17th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
15:58:1552.022
15:56:4452.0351
15:35:4252.03100
15:30:0252.11100
15:20:2052.21100
14:48:5752.31186
13:50:4752.18100
13:16:5752.08100
13:16:5752.08100
13:09:1752.003
Bats BZX Real-time Quote - 17:29:46
Daily Spread
Premium/Discount
Volume

BIB Factset Analytics Block Liquidity

As of 11/20/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BIB. BIB is rated a 5 out of 5.

BIB Summary Data

ProShares
04/08/10
Open-Ended Fund
0.95%
$436.75M
0.15%

BIB Portfolio Data

0.00%
12/26/17

BIB Index Data

Market Cap
NASDAQ - Listed
N/A

BIB Fund Structure

Yes
No
No Policy
N/A
N/A
Low
2
Daily

BIB Tax Exposures

20% / 39.6%
--
No

BIB Tradability

245,998
$14.3M
214,360
$12.28M
0.15%
-0.02%
0.31% / -0.2%
None
50,000
4.29
0.01%
6,748
$53.04
5

BIB MSCI ESG Ratings

4.42 / 10
--
17.03
--
35.87%
19.07